|
IM-MV 18-009_000
|
Universitair Medisch Centrum Utrecht
|
Clinical testing of KITE-585, an autologous cellular immunotherapy composed of T cells genetically modified ex vivo to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumor cells
|
|
Ontwerpbesluit genomen
|
